Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 67

1.

KASL clinical practice guidelines: management of hepatitis C.

Korean Association for the Study of the Liver (KASL).

Clin Mol Hepatol. 2014 Jun;20(2):89-136. doi: 10.3350/cmh.2014.20.2.89. Epub 2014 Jun 30. No abstract available.

PMID:
25032178
[PubMed - in process]
Free PMC Article
2.

Naturally occurring mutations in the nonstructural region 5B of hepatitis C virus (HCV) from treatment-naïve Korean patients chronically infected with HCV genotype 1b.

Kim DW, Lee SA, Kim H, Won YS, Kim BJ.

PLoS One. 2014 Jan 29;9(1):e87773. doi: 10.1371/journal.pone.0087773. eCollection 2014.

PMID:
24489961
[PubMed - in process]
Free PMC Article
3.

Between Scylla and Charybdis: the role of the human immune system in the pathogenesis of hepatitis C.

Spengler U, Nischalke HD, Nattermann J, Strassburg CP.

World J Gastroenterol. 2013 Nov 28;19(44):7852-66. doi: 10.3748/wjg.v19.i44.7852. Review.

PMID:
24307779
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Transmission of hepatitis C virus: self-limiting hepatitis or chronic hepatitis?

Saito T, Ueno Y.

World J Gastroenterol. 2013 Nov 7;19(41):6957-61. doi: 10.3748/wjg.v19.i41.6957. Review.

PMID:
24222939
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Factors associated with uptake, adherence, and efficacy of hepatitis C treatment in people who inject drugs: a literature review.

Mravčík V, Strada L, Stolfa J, Bencko V, Groshkova T, Reimer J, Schulte B.

Patient Prefer Adherence. 2013 Oct 17;7:1067-75. doi: 10.2147/PPA.S49113. Review.

PMID:
24204126
[PubMed]
Free PMC Article
6.

IL28B gene polymorphisms and US liver fatty changes in patients who spontaneously cleared hepatitis C virus infection.

Taliani G, Spaziante M, Biliotti E, Borro M, Palazzo D, Grieco S, Franchi C, Iaiani G, Furlan C, Gallinaro V, Simmaco M.

PLoS One. 2013 Aug 1;8(8):e67301. doi: 10.1371/journal.pone.0067301. Print 2013.

PMID:
23936294
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDA.

Grint D, Peters L, Schwarze-Zander C, Beniowski M, Pradier C, Battegay M, Jevtovic D, Soriano V, Lundgren JD, Rockstroh JK, Kirk O, Mocroft A; EuroSIDA in EuroCoord.

HIV Med. 2013 Nov;14(10):614-23. doi: 10.1111/hiv.12068. Epub 2013 Jul 19.

PMID:
23869664
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Role of IL28B gene polymorphism and cell-mediated immunity in spontaneous resolution of acute hepatitis C.

Spada E, Amoroso P, Taliani G, Zuccaro O, Chiriacò P, Maio P, Maio G, Esposito ML, Mariano C, Rinaldi R, Bellissima P, Tosti ME, Del Porto P, Francavilla R, Mellace V, Garbuglia AR, Folgori A, Mele A; Acute Hepatitis Italian Study Group.

Clin Infect Dis. 2013 Sep;57(6):803-11. doi: 10.1093/cid/cit402. Epub 2013 Jun 19.

PMID:
23784926
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Ever closer to a prophylactic vaccine for HCV.

Swadling L, Klenerman P, Barnes E.

Expert Opin Biol Ther. 2013 Aug;13(8):1109-24. doi: 10.1517/14712598.2013.791277. Epub 2013 May 7. Review.

PMID:
23651228
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Clinical characteristics, spontaneous clearance and treatment outcome of acute hepatitis C: a single tertiary center experience.

Deutsch M, Papadopoulos N, Hadziyannis ES, Koskinas J.

Saudi J Gastroenterol. 2013 Mar-Apr;19(2):81-5. doi: 10.4103/1319-3767.108479.

PMID:
23481134
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

New tools in HCV diagnosis, in light of the enhanced awareness and the new drugs for treatment: SMARTube and stimmunology.

Gorodin S, Unal S, Wang Y, Mikhaylov MI, Bigbulatova L, Jehuda-Cohen T.

ScientificWorldJournal. 2013;2013:389780. doi: 10.1155/2013/389780. Epub 2013 Feb 14.

PMID:
23476130
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Pegylated interferon and ribavirin treatment for hepatitis C virus infection.

Palumbo E.

Ther Adv Chronic Dis. 2011 Jan;2(1):39-45. doi: 10.1177/2040622310384308.

PMID:
23251740
[PubMed]
Free PMC Article
13.

Acute hepatitis C in an HIV-infected patient: a case report and review of literature.

Driver TH, Terrault N, Saxena V.

J Gen Intern Med. 2013 May;28(5):734-8. doi: 10.1007/s11606-012-2258-3. Epub 2012 Nov 14. Review.

PMID:
23151989
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Frequent longitudinal sampling of hepatitis C virus infection in injection drug users reveals intermittently detectable viremia and reinfection.

Page K, Osburn W, Evans J, Hahn JA, Lum P, Asher A, Delwart E, Tobler L, Cox AL, Busch MP.

Clin Infect Dis. 2013 Feb;56(3):405-13. doi: 10.1093/cid/cis921. Epub 2012 Oct 22.

PMID:
23090930
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

SASLT practice guidelines: management of hepatitis C virus infection.

Alghamdi AS, Sanai FM, Ismail M, Alghamdi H, Alswat K, Alqutub A, Altraif I, Shah H, Alfaleh FZ; Saudi Association for the Study of Liver Diseases and Transplantation.

Saudi J Gastroenterol. 2012 Sep;18 Suppl:S1-32. No abstract available.

PMID:
23006491
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Analysis of the virus dynamics model reveals that early treatment of HCV infection may lead to the sustained virological response.

Gupta S, Singh R.

PLoS One. 2012;7(7):e41209. doi: 10.1371/journal.pone.0041209. Epub 2012 Jul 24.

PMID:
22911761
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Glances in Immunology of HIV and HCV Infection.

Quaranta MG, Mattioli B, Vella S.

Adv Virol. 2012;2012:434036. doi: 10.1155/2012/434036. Epub 2012 Jun 7.

PMID:
22754568
[PubMed]
Free PMC Article
18.

Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine.

Grebely J, Prins M, Hellard M, Cox AL, Osburn WO, Lauer G, Page K, Lloyd AR, Dore GJ; International Collaboration of Incident HIV and Hepatitis C in Injecting Cohorts (InC3).

Lancet Infect Dis. 2012 May;12(5):408-14. doi: 10.1016/S1473-3099(12)70010-5. Review.

PMID:
22541630
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Treatment of hepatitis C as prevention: a modeling case study in Vietnam.

Durier N, Nguyen C, White LJ.

PLoS One. 2012;7(4):e34548. doi: 10.1371/journal.pone.0034548. Epub 2012 Apr 12.

PMID:
22511949
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

The more you look, the more you find: effects of hepatitis C virus testing interval on reinfection incidence and clearance and implications for future vaccine study design.

Vickerman P, Grebely J, Dore GJ, Sacks-Davis R, Page K, Thomas DL, Osburn WO, Cox AL, Aitken CK, Hickman M, Hellard M; International Collaboration of Incident HIV and Hepatitis C in Injecting Cohorts (InC3).

J Infect Dis. 2012 May 1;205(9):1342-50. doi: 10.1093/infdis/jis213. Epub 2012 Mar 29. Erratum in: J Infect Dis. 2012 Aug 15;206(4):624. InC Collaborative Group [corrected to International Collaboration of Incident HIV and Hepatitis C in Injecting Cohorts (InC3)].

PMID:
22457292
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk